Evidence map›Paper›PMID 11391035›Full record

ReviewHeart failure reviews2001

Mitral valve reconstruction in the patient with heart failure.

S F Bolling

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Heart failure reviews, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00428103 (Destiny Trial), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00428103 nawithdrawnnot on this mapstarted 2006, after this paper: background citation

Destiny Trial: Effects of Mitral Valve Annuloplasty With the Geoform Ring on Left Ventricular Geometry and Function in Patients With Cardiomyopathy

TypeinterventionalSponsorJuan Crestanello, MDRan2006 to 2012Enrolled0ConditionsMitral Valve Regurgitation, Congestive Heart Failure, CardiomyopathyArms3 dimensional echocardiography
3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Management of mitral regurgitation during left ventricular reconstruction for ischemic heart failure.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 2012
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Mitral Valve Repair in the Treatment of Heart Failure.Current treatment options in cardiovascular medicine · 2004
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

S F BollingUniversity of Michigan Hospital, Section of Cardiac Surgery, 1500 East Medical Center Drive, 2120 Taubman Center, Box 0348, Ann Arbor, MI 48109-0348, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Secondary MR is a complication of end-stage cardiomyopathy and is associated with a poor prognosis and is due to progressive mitral annular dilation and alteration in LV geometry. A vicious cycle of continuing volume overload, ventricular dilation, progression of annular dilation, increased LV wall tension and worsening MR and CHF occur. The mainstay of medical therapy is diuretics and afterload reduction, and is associated with poor long-term survival in these patients with CHF and MR. However, surgical intervention in the form of undersized, 'overcorrecting' mitral valve repair has shown great promise and is an area of ongoing investigation.

Indexed as

Heart FailureHumansMitral ValveMitral Valve Insufficiency

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.